Cited by 13Uterine Myomas and TreatmentsEndometrial and Cervical Cancer TreatmentsPelvic floor disorders treatments

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

The Risk of Primary Uterine and Cervical Cancer After Hysteropexy

Kurian, Rebecca, Kirchhoff-Rowald, Amelia, Sahil, Suman, Cheng, An-Lin, Wang, Xi, Shepherd, Jonathan P., Sutkin, Gary·2021·Female Pelvic Medicine & Reconstructive Surgery

Abstract

Objective: The aim of the study was to determine the rate of subsequent uterine/cervical cancer after hysteropexy compared with hysterectomy with apical prolapse repair. Methods: The study used a retrospective cohort of women with uterovaginal prolapse using the Cerner Health Facts database between 2010 and 2018. We identified sacrospinous or uterosacral ligament suspensions or sacral colpopexy/hysteropexy and excluded those with previous hysterectomy. We used the International Classification of Diseases , Ninth Revision and International Classification of Diseases, Tenth Revision codes for endometrial cancer/hyperplasia and cervical cancer and then reviewed each case, excluding those whose cancer existed at time of prolapse repair. Given that 0 cancer cases were identified, we used Wilson, Jeffreys, Agresti-Coull, Clopper-Pearson, and Rule of 3 to define 95% confidence intervals to estimate the highest possible rate of cancer in each cohort. Results: A total of 8,927 patients underwent apical prolapse surgery. Of 4,510 with uterovaginal prolapse, 755 (16.7%) underwent hysteropexy. Seventy one with hysterectomy and 5 with hysteropexy had codes for subsequent gynecologic cancer but were excluded on further review. This left 0 gynecologic cancer cases with the largest 95% confidence interval of 0%–0.61% for hysteropexy versus 0%–0.13% for hysterectomy ( P > 0.05). The hysteropexy cohort was older (62.6 years vs 57.3 years, P < 0.0001), more likely to have public insurance (51.0% vs 37.9%, P < 0.0001), and less likely to smoke (4.5% vs 7.6%, P = 0.0026). Median follow-up was longer after hysteropexy (1,480 days vs 1,164 days, P < 0.0009). Conclusions: We can say with 95% certainty that uterine or cervical cancer will develop after hysteropexy in fewer than 0.61% of women, which was not different if hysterectomy was performed. This should be included in preoperative counseling for hysteropexy. Studying longer follow-up after hysteropexy may capture more cases of subsequent cancer development.

Overview

Integrity signals

Registry

Crossref · 10.1097/spv.0000000000001030

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Kurian, R., Kirchhoff-Rowald, A., Sahil, S., Cheng, A.-L., Wang, X., Shepherd, J. P., & Sutkin, G.
Affiliations
  • University of Missouri–Kansas City (US)
  • Quinnipiac University (US)
Corresponding author
  • Kurian, Rebecca
  • Kirchhoff-Rowald, Amelia
  • Sahil, Suman
  • Cheng, An-Lin
  • Wang, Xi
  • Sutkin, Gary
Venue
Female Pelvic Medicine & Reconstructive Surgery
Published
2021-03
Volume
27
Issue
3
Pages
e493-e496
ISSN
  • 2151-8378 (ISSN-L)
  • 2154-4212
OpenAlex
W3129519118
Cited by
13
References
14
Citations by year
2026: 3 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 1
FWCI
1.82
Type
journal article
Language
en
Open access
closed
Locations
  • Urogynecology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
  • Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
Keywords
hysteropexy, hysterectomy, uterovaginal prolapse, uterine cancer, cervical cancer, endometrial cancer, sacrospinous ligament suspension, uterosacral ligament suspension, sacrocolpopexy, cancer risk, preoperative counseling, pelvic organ prolapse surgery, cancer incidence estimation
MeSH terms
Uterine Cervical Neoplasms, Female, Humans, Ligaments, Retrospective Studies, Risk Factors, Gynecologic Surgical Procedures, Uterine Prolapse, Databases, Factual

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review